Your browser doesn't support javascript.
loading
Two-year clinical outcomes after paclitaxel-eluting stent or brachytherapy treatment for bare metal stent restenosis: the TAXUS V ISR trial.
Ellis, Stephen G; O'Shaughnessy, Charles D; Martin, Steven L; Kent, Kenneth; McGarry, Thomas; Turco, Mark A; Kereiakes, Dean J; Popma, Jeffrey J; Friedman, Mark; Koglin, Joerg; Stone, Gregg W.
Affiliation
  • Ellis SG; Department of Cardiovascular Medicine, Cleveland Clinic, 9500 Euclid Avenue, F25, Cleveland, OH 44195, USA. elliss@ccf.org
Eur Heart J ; 29(13): 1625-34, 2008 Jul.
Article in En | MEDLINE | ID: mdl-18556716
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brachytherapy / Paclitaxel / Coronary Restenosis / Tubulin Modulators / Drug-Eluting Stents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Heart J Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brachytherapy / Paclitaxel / Coronary Restenosis / Tubulin Modulators / Drug-Eluting Stents Type of study: Clinical_trials / Etiology_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: Eur Heart J Year: 2008 Document type: Article Affiliation country: Estados Unidos Country of publication: Reino Unido